SEARCH

SEARCH BY CITATION

Referencias bibliográficas

  • 1
    Brunt EM. Histological assessment of nonalcoholic fatty liver disease in adults and children. Clin Liver Dis 2012;1:108-111.
  • 2
    Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 2012;142:1592-1609.
  • 3
    Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999;116:1413-1419.
  • 4
    Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999;94:2467-2474.
    Direct Link:
  • 5
    Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41:1313-1321.
  • 6
    Brunt EM, Kleiner DE, Wilson L, Belt P, Neuschwander-Tetri BA; for NASH Clinical Research Network. The NAS and the histopathologic diagnosis of NASH: distinct clinicopathologic meanings. Hepatology 2011;53: 810-820.
  • 7
    Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346: 1221-1231.
  • 8
    Kleiner DE, Brunt EM. Nonalcoholic fatty liver disease: pathologic patterns and biopsy evaluation in clinical research. Semin Liver Dis 2012; 32:3-13.
  • 9
    Noureddin M, Loomba R. Nonalcoholic fatty liver disease: indications for liver biopsy and noninvasive biomarkers. Clin Liver Dis 2012;1:104-107.